Evaluating a radiotherapy deep learning synthetic CT algorithm for PET-MR attenuation correction in the pelvis

Author:

Wyatt Jonathan J.ORCID,Kaushik Sandeep,Cozzini Cristina,Pearson Rachel A.,Petrides George,Wiesinger Florian,McCallum Hazel M.,Maxwell Ross J.

Abstract

Abstract Background Positron emission tomography–magnetic resonance (PET-MR) attenuation correction is challenging because the MR signal does not represent tissue density and conventional MR sequences cannot image bone. A novel zero echo time (ZTE) MR sequence has been previously developed which generates signal from cortical bone with images acquired in 65 s. This has been combined with a deep learning model to generate a synthetic computed tomography (sCT) for MR-only radiotherapy. This study aimed to evaluate this algorithm for PET-MR attenuation correction in the pelvis. Methods Ten patients being treated with ano-rectal radiotherapy received a $$^{18}$$ 18 F-FDG-PET-MR in the radiotherapy position. Attenuation maps were generated from ZTE-based sCT (sCTAC) and the standard vendor-supplied MRAC. The radiotherapy planning CT scan was rigidly registered and cropped to generate a gold standard attenuation map (CTAC). PET images were reconstructed using each attenuation map and compared for standard uptake value (SUV) measurement, automatic thresholded gross tumour volume (GTV) delineation and GTV metabolic parameter measurement. The last was assessed for clinical equivalence to CTAC using two one-sided paired t tests with a significance level corrected for multiple testing of $$p \le 0.05/7 = 0.007$$ p 0.05 / 7 = 0.007 . Equivalence margins of $$\pm 3.5\%$$ ± 3.5 % were used. Results Mean whole-image SUV differences were −0.02% (sCTAC) compared to −3.0% (MRAC), with larger differences in the bone regions (−0.5% to −16.3%). There was no difference in thresholded GTVs, with Dice similarity coefficients $$\ge 0.987$$ 0.987 . However, there were larger differences in GTV metabolic parameters. Mean differences to CTAC in $${\mathrm {SUV}}_{\max}$$ SUV max were $$1.0 \pm 0.8\%$$ 1.0 ± 0.8 % (± standard error, sCTAC) and $$-4.6 \pm 0.9\%$$ - 4.6 ± 0.9 % (MRAC), and $$1.0 \pm 0.7\%$$ 1.0 ± 0.7 % (sCTAC) and $$-4.3 \pm 0.8\%$$ - 4.3 ± 0.8 % (MRAC) in $${\mathrm {SUV}}_{\rm mean}$$ SUV mean . The sCTAC was statistically equivalent to CTAC within a $$\pm 3.5\%$$ ± 3.5 % equivalence margin for $${\mathrm {SUV}}_{\max}$$ SUV max and $${\mathrm {SUV}}_{\rm mean}$$ SUV mean ($$p = 0.007$$ p = 0.007 and $$p = 0.002$$ p = 0.002 ), whereas the MRAC was not ($$p = 0.88$$ p = 0.88 and $$p = 0.83$$ p = 0.83 ). Conclusion Attenuation correction using this radiotherapy ZTE-based sCT algorithm was substantially more accurate than current MRAC methods with only a 40 s increase in MR acquisition time. This did not impact tumour delineation but did significantly improve the accuracy of whole-image and tumour SUV measurements, which were clinically equivalent to CTAC. This suggests PET images reconstructed with sCTAC would enable accurate quantitative PET images to be acquired on a PET-MR scanner.

Funder

EIT Health

Publisher

Springer Science and Business Media LLC

Reference37 articles.

1. Leibfarth S, Simoncic U, Mönnich D, Welz S, Schmidt H, Schwenzer N, Zips D, Thorwarth D. Analysis of pairwise correlations in multi-parametric PET/MR data for biological tumor characterization and treatment individualization strategies. Eur J Nucl Med Mol Imaging. 2016;43(7):1199–208.

2. Catalano OA, Lee SI, Parente C, Cauley C, Furtado FS, Striar R, Soricelli A, Salvatore M, Li Y, Umutlu L, Cañamaque LG, Groshar D, Mahmood U, Blaszkowsky LS, Ryan DP, Clark JW, Wo J, Hong TS, Kunitake H, Bordeianou L, Berger D, Ricciardi R, Rosen B. Improving staging of rectal cancer in the pelvis: the role of PET/MRI. Eur J Nucl Med Mol Imaging. 2021;48(4):1235–45. https://doi.org/10.1007/s00259-020-05036-x.

3. Amorim BJ, Hong TS, Blaszkowsky LS, Ferrone CR, Berger DL, Bordeianou LG, Ricciardi R, Clark JW, Ryan DP, Wo JY, Qadan M, Vangel M, Umutlu L, Groshar D, Cañamaques LG, Gervais DA, Mahmood U, Rosen BR, Catalano OA. Clinical impact of PET/MR in treated colorectal cancer patients. Eur J Nucl Med Mol Imaging. 2019;46(11):2260–9. https://doi.org/10.1007/s00259-019-04449-7.

4. Fiorentino A, Laudicella R, Ciurlia E, Annunziata S, Lancellotta V, Mapelli P, Tuscano C, Caobelli F, Evangelista L, Marino L, Quartuccio N, Fiore M, Borghetti P, Chiaravalloti A, Ricci M, Desideri I, Alongi P. Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2. Crit Rev Oncol Hematol. 2019;139:117–24. https://doi.org/10.1016/j.critrevonc.2019.03.008.

5. Couwenberg AM, Burbach JPM, Berbee M, Lacle MM, Arensman R, Raicu MG, Wessels FJ, Verdult J, Roodhart J, Reerink O, Hoendervangers S, Buijsen J, Grabsch HI, Pronk A, Consten ECJ, Smits AB, Heikens JT, Appelt AL, van Grevenstein WMU, Verkooijen HM, Intven MPW. Efficacy of dose-escalated chemoradiation on complete tumor response in patients with locally advanced rectal cancer (RECTAL-BOOST): a phase 2 randomized controlled trial. Int J Radiat Oncol Biol Phys. 2020;108(4):1008–18. https://doi.org/10.1016/j.ijrobp.2020.06.013.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3